End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment.

Source:http://linkedlifedata.com/resource/pubmed/id/11773892

Transplantation 2001 Dec 27 72 12 1934-9

Download in:

View as

Triples

General Info

PMID
11773892